3-D Printing Is Ready for Surgery; Surgeons Practice With Replicas of Patients’ Organs Before Surgery

Updated April 8, 2013, 9:31 p.m. ET

3-D Printing Is Ready for Surgery

Surgeons Practice With Replicas of Patients’ Organs Before Surgery

By JURO OSAWA

MK-CC250_3DPRIN_G_20130408181531

Japanese surgeon Maki Sugimoto holds a 3-D replica of a patient’s liver built by printers using acrylic resin.

Surgeons at a hospital in Japan recently faced a dilemma before transplanting a parent’s liver into a child: How exactly to trim the organ to fit the space in the child’s smaller cavity while preserving its functions.

So they took a knife to a three-dimensional replica of the donor’s liver built by a machine that resembles an office printer. The model helped the doctors figure out where to carve it, leading to a successful transplant last month.

Surgeons are finding industrial 3-D printers to be a lifesaver on the operating table. This technology, also known as additive manufacturing, has long produced prototypes of jewelry, electronics and car parts. But now these industrial printers are able to construct personalized copies of livers and kidneys, one ultrathin layer at a time.The medical field in particular is expected to benefit greatly from 3-D printing, also known as additive manufacturing. Scientists are working on ways to print embryonic stem cells and living human tissue with the aim to produce body parts that can be directly attached to or implanted in the body.

MK-CC251_3dPrin_G_20130408173036

A 3-D replica of a patient’s liver.

Printing out artificial body parts is likely many years away, but advanced 3-D printers are starting to make their mark at hospitals.

Two of the world’s largest industrial 3-D printer makers, U.S. companiesStratasys Ltd. SSYS -1.61% and 3D Systems Corp., DDD +0.64% offer machines that can replicate human organs.

Using medical images such as CT scans, these printers can construct translucent models made with variations of acrylic resin, enabling surgeons to understand the internal structure of the livers and kidneys, such as the direction of blood vessels or the exact location of a tumor.

A more realistic-looking model, made partly of polyvinyl alcohol, assimilates the wetness and texture of a real human liver, making it more suitable to cut with a surgical knife.

It usually takes several hours to a half day to print a copy of a human organ depending on its size. The whole process, including the time to convert the original medical images to printable 3-D data, usually takes a few days.

“Today, most medical uses [of 3-D printers] are still experimental, but we are seeing more and more applications,” said David Reis, chief executive of Stratasys, based in Eden Prairie, Minn.

There are many hurdles, to be sure, before the technology can become widespread in operating rooms at hospitals world-wide. The kinds of advanced 3-D printers used to create organ models can cost between $250,000 to $500,000, making it difficult for smaller hospitals to install them.

As most doctors don’t know how to use those printers, hospitals need engineers to operate the printers and help convert images from computed tomography and other medical equipment to 3-D data that can be printed out.

Maki Sugimoto, a surgeon at Japan’s Kobe University Hospital who began using replicas of patients’ organs for navigation purposes in 2011, employs Japanese company Fasotec Co. to produce the 3-D models. Fasotec acts as an intermediary between the hospitals and printers.

Fasotec says it is still rare for surgeons to request 3-D replicas of internal organs—more typical are basic 3-D copies of bones.

At Hong Kong’s Dental Implant & Maxillofacial Centre, oral surgeons have been using 3-D printers for a few years to create not only a copy of the patient’s jaw to plan surgeries, but also a custom-made surgery template that can be placed inside the patient’s mouth during the operation so the doctor knows exactly where to insert implants.

Efforts to promote 3-D printing for surgical purposes come at a time when the technology is evolving faster, drawing renewed attention in the media and generating buzz among consumers world-wide.

While 3-D printing has existed for about 30 years, the rapid progress in technology in recent years, as well as more affordable price tags, has made the technology more attractive to industries and consumers.

In the U.S., some universities and corporate laboratories are conducting research on “bioprinting,” or artificial construction of body parts using living human tissue. Still in the experimental phase, researchers hope one day to produce personalized body parts on demand, despite many hurdles including ethical questions.

Mr. Sugimoto believes that longer-term, the technology could help younger, less experienced surgeons practice with accurate copies before surgery.

If doctors feel more confident about the surgeries they are about to perform, patients will feel more comfortable, Mr. Sugimoto said.

“The potential impact is no smaller than the shift from fixed-line phones to mobile phones,” he said.

About bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: